Open Access

Clinical implications for patients at persistent ASCVD risk

Congress Session

About the speaker

Doctor Joseph Saseen

University of Colorado, Aurora (United States of America)
1 presentation
0 follower

4 more presentations in this session

Clinical trial updates

Speaker: Doctor C. Ballantyne (Houston, US)

Thumbnail

The future of lipid management: new therapies for LDL-C lowering

Speaker: Doctor H. Bays (Louisville, US)

Thumbnail

Post-activity quiz and discussion

Speaker: Doctor P. MORRIS (Charleston, US)

Thumbnail

Questions and answers / Panel discussion

Thumbnail

Access the full session

Targeting of PCSK9 with siRNA for LDL-C reduction in a high-risk population

Speakers: Doctor J. Saseen, Doctor C. Ballantyne, Doctor H. Bays, Doctor P. MORRIS
Thumbnail

About the event

Image

ESC CONGRESS 2019

31 August - 4 September 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk